Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nidan, many here are sorry for the lost of your brother for you and your families ... also, for your loss, bullet, too.
I heard about Alzheimer's in the mid-80's when my aunt was diagnosed with it. My uncle couldn't handle it and died within a year while Aunt Liz lasted until 1988. That is why I've been keen on a solution ever since then and thanks to Patrick Cox, I invested in Anavex in 2008-9. Dr. Missling was the correct move in 2013 (too bad it wasn't made earlier) ...
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
P.S. Great posts by a number of people today, especially you and mrp. Thanks to all.
FYI - While I like the $6.50 range, ANVS is up >$1, to $12.80, but no news given.
What was the change for State Street, Talon?
TIA
I almost choked on my TnT. Very funny 😆
bas and froll, how would you summarize the discussion: was the IR person honest, embellishing, hesitant, confused, engaged, indifferent, too casual, respectful, uninterested in your question et al? Did either of you ask about the status of other drugs as to what Anavex might perceive about its competitors, other that the brain-shrinking mabs?
TIA - I appreciate the thoughts of each of you.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Only a few weeks away.
Housekeeping items ... and some humor though true:
go avxl - Please change your moniker to "anti-avxl" as nothing you post, comment on or express an emoji is ever a "go avxl" opinion. Newbies might believe your moniker is for Anavex to succeed, which we know is not true. 😉
Investor, you, too, should make a change with your tag line as your remarks don't really reflect the "... the sooner we will get rich!" Maybe, it should read:
This is pointing towards you, Investor!!
https://www.bizpacreview.com/2024/01/16/dr-drew-warns-of-extremely-worrisome-data-and-trends-revealed-in-marijuana-studies-1428111/?utm_campaign=bizpac&utm_content=Newsletter&utm_medium=Newsletter&utm_source=Get%20Response&utm_term=EMAIL
Possibly, it won't take long to find enough people for the 3-71 trial announced today.
Wishful thinking!
I like Lundbeck, as it is involved Anavex now via the Consortium as is Merck and Takeda ... enough power these to cover the non-China world.
george, this would be a great week to release the peer review paper on AD P2b/3 trial. The folks in Davos might take note, given Gates' interview about healthcare costs becoming unaffordable. Might catch the attention of some of the Davos crowd, who though snobs and elitist, hold the $$ strings.
Tomorrow would be nice, TGD!! 😉
I believe psychologists would claim that those who 👍️ their own posts are people of very low esteem.
kund, I think you wear that shoe! Also, don't break your arms, patting yourself on the back.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
The arguments that you, Doc328, Joseph, Steady and froll make are only a pile of 💩 that stink 🦨 to high heaven.
You (and the above) always use %'s that indicate 2-73 isn't up to snuff and demonize and degrade those %'s that indicate its efficiency and its chance of approval.
boi's comment that 85% of drugs reaching the level that has been attained by 2-73 in the EMA approval process are eventually approved is a % for the population reaching that level. Nothing more!
Then, given the new "Hos" breakdown of 2-73's performance, which you and the above claim to be doing in support of your group's diminished %, is further evidence that "you" are not looking at the numbers objectively, but with pre-determined negative views to castigate 2-73 into an inferior drug.
We will all see which group is correct when the EMA decides (or some other agency). The losers should apologize when that decision(s) happens.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
vg, I think george's idea that someone placed the number of shares in the wrong column is correct, given the other notation son the form.
P.S. Agree that kevin was not being the helpful poster s/he usually is.
Here, pogue, from Anavex web site under "Investor Material."
https://jpmorgan.metameetings.net/events/healthcare24/sessions/49893-anavex-life-sciences/webcast/general_signin?gpu_only=true&kiosk=true
vg, if not answered before, I see "A" in transaction code for both and "D" in ownership column for both (per george's post with the links).
Seems consistent for each with the other.
Sorry, if I did not understand your concern.
P.S. $10.09 was ending price on June 27, 2022.
gerry, which journals are in the Tier 1 range from your experience? Why highlight Lancet at this time?
Hosai, or whatever name you went by in an earlier life here, IMO, the markets Anavex is going after are larger that Karuna's when looking at the big picture though Karuna is in the neuro field as well. Should Anavex reach the same stages as Karuna, it will commend a larger price if it were to sell ... which is not my choice for a long time.
Congrats to KRTX; now, let's get it done for your stakeholders, TGD and Anavex people!!
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
plex, give 12x a 👍️ if you like the post ... which you seem to like!
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
As a fellow 🦨, he never had a foot ... other than 💩!!
Given you are a BOT ... who cares!!! 💩🦨
I don't believe the LP has completed the OLE, thus no data. Positive is that 93% are in the Compassionate Use group after the OLE.
He was, probably, addressing the BMY purchase of Karuna Therapeutics, Inc. (KRTX), announced last month. One similarity is it had no commercial operations either, receiving some "license and other revenue", per last year's 10-K.
Still, don't see slide deck on Anavex web site.
A trading halt would be really nice! 😉
Hopefully, mike, at a minimum, we'll see an updated slide deck, given that the last one was in May.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
From Zack's earlier today, if not posted previously:
Anavex Life Sciences is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The stock saw a positive earnings estimate revision of 4 cents over the past seven days for the fiscal year ending January 2024. AVXL has a market cap of $493.3 million and has plunged 35.4% in a week.
Anavex Life Sciences has a Zacks Rank #2 and a solid Momentum Score of A.
https://finance.yahoo.com/news/5-small-cap-stocks-play-145900292.html
xo, the other point to make is that the placebo parents/caregivers have seen true improvement in the OLE and have re-upped to the Compassionate Use Authorization (CUA). Otherwise, if they saw no improvement in the OLE, they would NOT have continued with the CUA. In fact, they might have asked to get the placebo again!
Let's interview some of those parents/caregivers.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
nidan, that is what I'm afraid will happen.
Source: Google search
Maybe, we'll see an 8-K Monday morning ... and if not, it might mean that Anavex doesn't believe it is a failed trial and it needs more time to analyze. 😉
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
plex, first, thanks for your kind comments. Yes, I'm still a strong WGT proponent, regardless of the Rett upset. I don't give up on my team because they lost one (Notre Dame v. Purdue, 1977).
I know it might be hard for Dr. Missling to admit and change course, but I think he and Anavex need to be more upfront and transparent as I noted yesterday in the post below:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173570974
There is probably more hope in that post than reality of a change at Anavex. But, TGD must be more disappointed than those supporters of WGT are and might be that a re-think is in order and that a little more openness might be affordable.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Kentucky, Anavex did not file an 8-K for the EMA PR either.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Percentage, mike, is a little better than 83%:
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
IMO, given the Rett setback, Anavex and TGD need to show to investors et al @ JPM (or before) an action plan on several fronts. My list would be:
1) Be upfront and discuss the plan for Rett in the regions where the trials were conducted, plus with the fda. This includes revealing some details on the OLE, separating the results, maybe showing the initial group stats and the tag-ons added to the trial as they may have been most effected by the Covid vaccine and the biggest impact on the stats. [All of this s/b readily available with computer power of its IT partner.] Also, if data were only recently received, state such.
- or -
1a) Present a darn strong case while those numbers are still significant enough to be filed its NDA's throughout the world.
2) Provide more specifics with the EMA submission for Alzheimer's. Discuss the next steps with TGA, UK and fda on Alzheimer's.
3) Be more forthcoming on the peer review papers for Alzheimer's and PDD.
4) Discuss the mystery disease, if still in picture after Rett. If it isn't, discuss why or how it gets back into the picture.
5) Consider a conference call after having a week or so to review the details of the Rett trial.
Anavex and TGD need to lose its smugness and obfuscation and be more transparent to gain back credibility. Pro-active JPM presentation that pulls back the curtain some on Anavex's future plans would be an indication that the organization knows which path it needs to take to receive approvals and to commercialize Blarcamesine.
Just my thoughts after a tough week with the markets and a skeptical partner.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
FYI - With the lowered SP and still believing in Anavex's future success, I'm taking advantage and moving stock from IRA account to a Roth IRA. I did this in 2023, too, though at higher prices.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Great to know, X. Keep taking that special concoction of yours; it is definitely working.
Peace,
powerwalker